Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Loestrin 24 Approved As First 24-Day Oral Contraceptive

This article was originally published in The Pink Sheet Daily

Executive Summary

Warner Chilcott beats out Berlex' Yaz as the first oral contraceptive approved in the U.S. with 24 active hormone days.

You may also be interested in...



Berlex’ Yaz Gains Indication For Premenstrual Dysphoric Disorder

The oral contraceptive is the first approved for the treatment of emotional and physical symptoms of PMDD.

Berlex’ Yaz Gains Indication For Premenstrual Dysphoric Disorder

The oral contraceptive is the first approved for the treatment of emotional and physical symptoms of PMDD.

Loestrin 24 Fe Ad Campaign Targets Consumers Not Currently On Birth Control

Ads for Warner Chilcott’s 24-day oral contraceptive debuted May 15, directing consumers to studies demonstrating a shorter period duration.

Related Content

Topics

UsernamePublicRestriction

Register

PS063728

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel